Connect with us

Tech

TechNigeria: A weekly digest of what went down in Nigeria’s tech space

Published

on

On the tech scene this week, we covered milestones recorded by Releaf, an agritech startup and 54gene, a heathtech startup.

We also featured the rebranding story of bus-hailing startup, Plentywaka.

Aside the release of iPhone13 by American mobile phone manufacturer Apple, there was no major news around product launch for the week.

Come, let’s revisit our top stories.

Releaf raises $4.2m

 

Releaf, a Nigerian agritech startup, announced raising US$4.2 million in seed equity and grant funding.

The startup, which develops proprietary hardware and software solutions to drive the industrialisation of food processing in Africa, is expected to support the development and scaling of technology solutions for the oil palm sector.

In 2017, the startup was founded as an ecommerce player but after two years, it shifted from ecommerce to palmoil production, an opportunity the founders spotted to be a cash-cow venture.

OurPass raises $1m

 

During the week, OurPass, Nigerian digital commerce startup, raised a US$1 million pre-seed round.

The raiser comes as the startup seeks to launch its mobile app to provide an easy, fast and secure way to shop online.

The startup offers one-click checkout technology for digital commerce in Africa.

READ ALSO: Nigeria’s 54gene raises $25m Series B. 1 other thing and a trivia

From Plentywaka to Treepz

 

Plentywaka, Nigerian shared mobility startup, has rebranded its venture, and would now continue business as Treepz.

The new branding is expected to help the mobility enterprise further its pan-African expansion plan.

The Lagos-based Plentywaka (Treepz) is a bus-hailing solution that allows commuters to book and pay for trips in real-time which was founded in 2019 by Onyeka Akumah, Johnny Ena, John Shaibu and Afolabi Oluseyi.

54gene’s big raiser

 

In a bid to advance global drug discovery capabilities, Nigerian startup 54gene secured US$25 million in a Series B round during the week.

The startup, which is a health technology company advancing African genomics research for improved global health outcomes, will use the fund to advance its capabilities to contribute to global drug discovery.

In 2019, the startup was launched as a research, services and development company, utilising human genetic data from diverse African populations to improve the development, availability and efficacy of medical products that will prove beneficial to Africans and the wider global population.

Remark:

Thank you for joining us this week. That will be all. Take care and stay here for more updates.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now

Investigations